Methylation-mediated BMPER expression in fibroblast activation in vitro and lung fibrosis in mice in vivo

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Huan, Caijuan ^a,b   Yang, Ting ^a   Liang, Jiurong ^b   Xie, Ting ^b   Cheng, Luis ^b   Liu, Ningshan ^b   Kurkciyan, Adrianne ^b   Monterrosa Mena, Jessica ^b   Wang, Chen ^c   Dai, Huaping ^a   Noble, Paul W ^b   Jiang, Dianhua ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BMPER PROTEIN, HUMAN; CARRIER PROTEIN; CROSSVEINLESS 2 PROTEIN, MOUSE; MESSENGER RNA; SMALL INTERFERING RNA;

ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CELL MOTION; CYTOLOGY; DNA METHYLATION; ENZYME IMMUNOASSAY; FEMALE; FIBROBLAST; GENETICS; HUMAN; IN VITRO STUDY; LUNG; LUNG FIBROSIS; METABOLISM; MOUSE; PATHOLOGY; PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL MOVEMENT; CELLS, CULTURED; DNA METHYLATION; FEMALE; FIBROBLASTS; HUMANS; IMMUNOENZYME TECHNIQUES; IN VITRO TECHNIQUES; LUNG; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PULMONARY FIBROSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84943338762     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14910     Document Type: Article

References (51)

1. ATS/ERS. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161, 646-664 (2000).
2. Olson, A. L. et al. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med 176, 277-284 (2007).
3. Thannickal, V. J., Zhou, Y., Gaggar, A., Duncan, S. R. Fibrosis: ultimate and proximate causes. J Clin Invest 124, 4673-4677 (2014).
4. Ding, Q. et al. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis. Drugs 71, 981-1001 (2011).
5. Noble, P. W., Barkauskas, C. E., Jiang, D. Pulmonary fibrosis: patterns and perpetrators. J Clin Invest 122, 2756-2762 (2012).
6. Sanders, Y. Y. et al. Altered DNA methylation profile in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 186, 525-535 (2012).
7. Huang, S. K. et al. Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice. Am J Pathol 177, 2245-2255 (2010).
8. Cisneros, J. et al. Hypermethylation-mediated silencing of p14(ARF) in fibroblasts from idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 303, L295-303 (2012).
9. Rabinovich, E. I. et al. Global methylation patterns in idiopathic pulmonary fibrosis. PLoS One 7, e33770 (2012).
10. Bird, A. P., Wolffe, A. P. Methylation-induced repression-belts, braces, and chromatin. Cell 99, 451-454 (1999).
11. Bechtel, W. et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 16, 544-550 (2010).
12. Santini, V., Kantarjian, H. M., Issa, J. P. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Intern Med 134, 573-586 (2001).
13. Dong, Y. et al. Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice. J Exp Med 212, 235-252 (2015).
14. Costello, C. M., Cahill, E., Martin, F., Gaine, S., McLoughlin, P. Role of gremlin in the lung: development and disease. Am J Respir Cell Mol Biol 42, 517-523 (2010).
15. Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., Gauldie, J. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 100, 768-776 (1997).
16. Gauldie, J., Bonniaud, P., Sime, P., Ask, K., Kolb, M. TGF-beta, Smad3 and the process of progressive fibrosis. Biochem Soc Trans 35, 661-664 (2007).
17. Bellusci, S., Henderson, R., Winnier, G., Oikawa, T., Hogan, B. L. Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis. Development 122, 1693-1702 (1996).
18. Geng, Y. et al. Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development. Proc Natl Acad Sci USA 108, 7058-7063 (2011).
19. Kariyawasam, H. H. et al. Basal expression of bone morphogenetic protein receptor is reduced in mild asthma. Am J Respir Crit Care Med 177, 1074-1081 (2008).
20. Koli, K. et al. Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis. Am J Pathol 169, 61-71 (2006).
21. Masterson, J. C. et al. Bone morphogenetic protein signalling in airway epithelial cells during regeneration. Cell Signal 23, 398-406 (2011).
22. Rosendahl, A. et al. Activation of bone morphogenetic protein/Smad signaling in bronchial epithelial cells during airway inflammation. Am J Respir Cell Mol Biol 27, 160-169 (2002).
23. Leask, A., Abraham, D. J. TGF-beta signaling and the fibrotic response. FASEB J 18, 816-827 (2004).
24. Selman, M., Pardo, A., Kaminski, N. Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs? PLoS Med 5, e62 (2008).
25. Goodwin, A., Jenkins, G. Role of integrin-mediated TGFbeta activation in the pathogenesis of pulmonary fibrosis. Biochem Soc Trans 37, 849-854 (2009).
26. Moser, M. et al. BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation. Mol Cell Biol 23, 5664-5679 (2003).
27. Helbing, T. et al. Inhibition of BMP activity protects epithelial barrier function in lung injury. J Pathol 231, 105-116 (2013).
28. Helbing, T. et al. BMP activity controlled by BMPER regulates the proinflammatory phenotype of endothelium. Blood 118, 5040-5049 (2011).
29. Dyer, L., Wu, Y., Moser, M., Patterson, C. BMPER-induced BMP signaling promotes coronary artery remodeling. Dev Biol 386, 385-394 (2014).
30. Funari, V. A. et al. BMPER mutation in diaphanospondylodysostosis identified by ancestral autozygosity mapping and targeted high-throughput sequencing. Am J Hum Genet 87, 532-537 (2010).
31. Heinke, J. et al. Bone morphogenetic protein modulator BMPER is highly expressed in malignant tumors and controls invasive cell behavior. Oncogene 31, 2919-2930 (2012).
32. Jiang, D. et al. Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4. J Clin Invest 120, 2049-2057 (2010).
33. Li, Y. et al. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. J Exp Med 208, 1459-1471 (2011).
34. Tager, A. M. et al. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 14, 45-54 (2008).
35. Farkas, L. et al. Transient overexpression of Gremlin results in epithelial activation and reversible fibrosis in rat lungs. Am J Respir Cell Mol Biol 44, 870-878 (2011).
36. Helbing, T. et al. Kruppel-like factor 15 regulates BMPER in endothelial cells. Cardiovasc Res 85, 551-559 (2010).
37. Jiang, D., Liang, J., Noble, P. W. Regulation of non-infectious lung injury, inflammation, and repair by the extracellular matrix glycosaminoglycan hyaluronan. Anat Rec (Hoboken) 293, 982-985 (2010).
38. Cai, G. Q. et al. Downregulation of FAK-related non-kinase mediates the migratory phenotype of human fibrotic lung fibroblasts. Exp Cell Res 316, 1600-1609 (2010).
39. Coward, W. R., Watts, K., Feghali-Bostwick, C. A., Jenkins, G., Pang, L. Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis. Mol Cell Biol 30, 2874-2886 (2010).
40. Hu, B., Gharaee-Kermani, M., Wu, Z., Phan, S. H. Epigenetic regulation of myofibroblast differentiation by DNA methylation. Am J Pathol 177, 21-28 (2010).
41. De Langhe, E. et al. Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis. Respir Res 16, 38 (2015).
42. Zeisberg, E. M., Zeisberg, M. The role of promoter hypermethylation in fibroblast activation and fibrogenesis. J Pathol 229, 264-273 (2013).
43. Xie, T. et al. Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation. Physiol Genomics 43, 479-487 (2011).
44. Xie, T. et al. MicroRNA-127 inhibits lung inflammation by targeting IgG Fcgamma receptor I. J Immunol 188, 2437-2444 (2012).
45. Sanders, Y. Y. et al. Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Am J Respir Cell Mol Biol 39, 610-618 (2008).
46. Hu, B., Gharaee-Kermani, M., Wu, Z., Phan, S. H. Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis. Am J Pathol 178, 1500-1508 (2011).
47. Yang, I. V. et al. Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 190, 1263-1272 (2014).
48. Meltzer, E. B. et al. Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle. BMC Med Genomics 4, 70 (2011).
49. Jiang, D. et al. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest 114, 291-299 (2004).
50. Ashcroft, T., Simpson, J. M., Timbrell, V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41, 467-470 (1988).
51. White, E. S. et al. Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10. Am J Respir Crit Care Med 168, 436-442 (2003).